Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Euglena Co., Ltd. (8EG.F)

Compare
2.6400
-0.0200
(-0.75%)
As of 8:08:41 AM GMT+2. Market Open.
Loading Chart for 8EG.F
  • Previous Close 2.6600
  • Open 2.6400
  • Bid 2.6800 x 40000
  • Ask 2.7800 x 40000
  • Day's Range 2.6400 - 2.6400
  • 52 Week Range 2.3800 - 3.3400
  • Volume 20
  • Avg. Volume 1
  • Market Cap (intraday) 366.736M
  • Beta (5Y Monthly) -0.05
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It also manufactures and sells foods and cosmetics using euglena. In addition, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. Further, it produces, processes, and sells euglena, chlorella, watermelon, midori koji, etc.; and manufactures and sells organic fertilizer. Additionally, the company provides genome analysis services. Euglena Co., Ltd. was incorporated in 2005 and is headquartered in Tokyo, Japan.

www.euglena.jp

897

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 8EG.F

View More

Performance Overview: 8EG.F

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

8EG.F
6.45%
Nikkei 225 (^N225)
13.83%

1-Year Return

8EG.F
16.98%
Nikkei 225 (^N225)
9.44%

3-Year Return

8EG.F
57.76%
Nikkei 225 (^N225)
26.89%

5-Year Return

8EG.F
52.86%
Nikkei 225 (^N225)
72.78%

Compare To: 8EG.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8EG.F

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    369.51M

  • Enterprise Value

    402.21M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.23

  • Price/Book (mrq)

    1.85

  • Enterprise Value/Revenue

    1.37

  • Enterprise Value/EBITDA

    17.24

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.37%

  • Return on Assets (ttm)

    0.28%

  • Return on Equity (ttm)

    -0.89%

  • Revenue (ttm)

    47.62B

  • Net Income Avi to Common (ttm)

    -650M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    20.63B

  • Total Debt/Equity (mrq)

    80.71%

  • Levered Free Cash Flow (ttm)

    854M

Research Analysis: 8EG.F

View More

Company Insights: 8EG.F

Research Reports: 8EG.F

View More